Ligand validation:7SLX

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7SLX_NAG_A_501	23%	71%	0.263	0.884	0.29	0.82	-	1	0	0	100%	1
7SLX_NAG_A_503	2%	74%	0.419	0.66	0.31	0.69	-	1	0	0	100%	1
4CYF_NAG_A_603	82%	47%	0.083	0.937	0.71	1.32	1	3	1	0	100%	1
4CYG_NAG_A_1524	81%	56%	0.104	0.956	0.56	1.11	-	2	1	0	100%	1
7SLV_NAG_A_501	51%	69%	0.142	0.896	0.31	0.85	-	1	0	0	100%	1
7SLY_NAG_A_501	32%	72%	0.204	0.877	0.31	0.75	-	1	0	0	100%	1
4CYY_NAG_A_533	26%	46%	0.236	0.879	0.53	1.53	-	3	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.